Omixon focuses on disrupting established molecular diagnostic markets with exciting new products and approaches to business.
The fastest sequencing-based HLA genotyping method
NanoTYPE™ is a nanopore-based long-read sequencing technology offering a revolutionary change in the clinical routine of HLA genotyping.
Monitoring absolute quantity of donor derived cfDNA
HoloGRAFT™ is a the first laboratory kit monitoring absolute quantity of donor derived cfDNA with short turnaround time- from DNA to results in 3 hours.
Multiplexing for HLA Experts
OmniType is a Multiplex Assay and Software product for use on Illumina sequencing platforms and offers a revolutionary single working-day workflow that allows processing of samples from DNA to Library in less than 6 hours.